M. T. Parmar, “Low Beta Is Not Low Risk: Evidence and Investor Implications from Five Indian Pharmaceutical Stocks, 2021–2025”, int. j. eng. mgmt. res., vol. 16, no. 3, pp. 113–125, Jun. 2026.